The Most Advanced Conference to Modernize Clinical Research
The 15th Annual DPHARM® offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders unveil the latest innovations on modernizing clinical trials.
DPHARM faculty challenge the clinical operations community to rethink how clinical research gets done to drive greater inclusivity and value for patients.
Convening 1000+ Attendees
DPHARM 2024 featured senior clinical operation executives with industry and patient thought leadership, and technologists showcasing the latest innovations in clinical trials driving efficiencies in operational processes and reducing patient, site and physician obstacles to participating in research.
2025 First Keynotes Announced
Patient
Advocate
Victoria Gray
First CRISPR Gene Therapy
Recipient for SCD
Geopolitical
Impact on R&D
Scott Gottlieb, MD
23rd Commissioner of the FDA
R&D
Leadership
Ken Frazier, JD
Former CEO and Current Executive Chairman
Merck
State of Clinical Trial Operations
.png)
Kenneth Getz, MBA
Executive Director & Professor
Tufts CSDD, Tufts University School of Medicine
2024 Senior Clinical Operations Leadership
.png)
Bari Kowal
SVP and Head, Development Operations, Portfolio Management and Biostatistics Data Management
Regeneron
Christoph Koenen, MD, MBA,
Head of Clinical Development and Operations, Pharmaceuticals R&D
Bayer
.png)
Melanie Ivarsson, OBE, PhD, MBA
SVP, Chief Development Officer
Moderna
Andy Lee,
SVP, Head, Global Clinical Trials Operations
Merck
Siân Ratcliffe, PhD
SVP, Head of Quantitative Sciences and Development Operations
Biogen
Deirdre BeVard
SVP, R&D Strategic Operations
CSL
Angela DeLuca, MBA, PMP
AVP, Head of Global Study Operations
Amgen
.jpg)
Candice Fitzgerald
Global Head Clinical Development and Operations Regions
Boehringer Ingelheim
Rosemary Rebuli
Global Head, Study and Site Operations, Global Clinical Trials
Novartis
Penny Carlson
VP, Head of Global Clinical Development Operations, Global Development Office, Research & Development
Takeda
Patient Disruptors
Emily Epstein
Patient Advocate
Yvonne Florence
Patient Advocate
Patrick Gee Sr, PhD, JLC
Patient Advocate, Founder & Chief Executive Hope Dealer
iAdvocate, Inc
.jpg)
Sabina Kineen
Patient Advocate
Barry Nelson
Patient Advocate
Karen Peterson
Founder & Chief Patient Advocate,
Karen’s Club
Rucha Shah
Patient Advocate and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group
DPHARM Idol Disrupt
DPHARM Idol Disrupt is a series of quick-fire presentations where you see bold and daring startups pitch their disruptive technologies to the most discerning judges. The Q&A provides amazing shared learnings on how to properly assess new technologies.
Congratulations to 2024 Winner, Power!
If you are interested in applying for a spot as a DPHARM Idol Disrupt 2025 presenter, email Meredith@tcfllc.org
DPHARM Commitment
- DPHARM combines TED-style talks with fireside chats, quick fires, panels and demos presentations showcasing innovations from leading Pharma R&D practitioners and from other industries.
- DPHARM underscores the promise and challenge of innovation in advancing drug development.
- DPHARM features new models and collaborations to get therapeutics to patients faster.
- DPHARM features the full spectrum of clinical research options and utilizes insights more appropriately.
- DPHARM is dedicated to challenging creative solutions and finding a way to implement them.
2025 Sponsors
.png)
